Insider Trading February 27, 2026

Live Oak Bancshares CEO Completes $786,998 Sale of 20,000 Shares

James S. Mahan III executed multi-day sales under a 10b5-1 plan as the stock trades below recent highs despite a strong quarterly report

By Hana Yamamoto LOB
Live Oak Bancshares CEO Completes $786,998 Sale of 20,000 Shares
LOB

Live Oak Bancshares Chief Executive Officer James S. Mahan III sold 20,000 shares of the company’s voting common stock across February 25 and 26, 2026, via trades executed through the James S. Mahan Revocable Trust and carried out under a Rule 10b5-1 plan adopted Aug. 27, 2025. The disposals totaled $786,998. The stock has declined over 11% in the prior week to $36.27 even as the company posted stronger-than-expected fourth-quarter 2025 results and received an analyst price-target increase.

Key Points

  • Live Oak Bancshares CEO James S. Mahan III sold 20,000 shares on February 25 and 26, 2026, for total proceeds of $786,998.
  • Trades were executed through the James S. Mahan Revocable Trust under a Rule 10b5-1 plan adopted August 27, 2025, with detailed per-trade weighted average prices and ranges disclosed.
  • The stock has fallen over 11% in the past week to $36.27, despite Live Oak reporting stronger-than-expected Q4 2025 results and receiving an analyst price-target increase.

James S. Mahan III, Chief Executive Officer of Live Oak Bancshares (NASDAQ:LOB), sold a total of 20,000 shares of the bank’s voting common stock over two days, according to a Form 4 filed with the Securities and Exchange Commission. The transactions took place on February 25 and February 26, 2026, and generated proceeds of $786,998.

The sales were executed in multiple trades and routed indirectly through the James S. Mahan Revocable Trust. Under the terms reported, the disposals were conducted pursuant to a Rule 10b5-1 trading plan that Mahan adopted on August 27, 2025.

Details of the trades show a split across the two days. On February 25, Mahan sold 7,463 shares at a weighted average price of $39.2119, with individual transaction prices in that batch ranging from $38.61 to $39.60. He also sold 2,537 shares that day at a weighted average price of $39.6454, with the individual prices for those shares ranging from $39.61 to $39.755.

On February 26, the CEO sold 8,754 shares at a weighted average price of $39.2899, with prices in that block ranging from $38.725 to $39.66. He additionally sold 1,246 shares at a weighted average price of $39.997; the individual prices reported for that tranche ranged from $39.795 to $40.16.

Following these transactions, the Form 4 indicates the number of shares owned after the sales is 2987844. The filing ties the sales to the previously noted 10b5-1 plan, which establishes prearranged trading parameters.


Market context around the sales shows the stock has been under pressure in recent sessions. The share price fell by more than 11% over the past week, trading at $36.27 at the time referenced in the filing.

At the same time, Live Oak reported robust operating results for the fourth quarter of 2025. The company posted earnings per share of $0.95, substantially ahead of the $0.57 projection and representing a 66.67% surprise to the upside. Revenue for the period was $172.91 million, above estimates by 14.27%.

Following the quarterly results, Keefe, Bruyette & Woods raised its price target on Live Oak Bancshares to $146 from $132 and maintained an Outperform rating. The report and the analyst action were associated with positive investor response in trading sessions mentioned in the filing.

The combination of the insider sales carried out under a Rule 10b5-1 plan, the recent pullback in the share price, and the company’s stronger-than-expected quarter are all documented in regulatory filings and analyst commentary cited in the company’s reporting. Where available, the filings provide the granular trade-level pricing and volumes summarized here.

Risks

  • Share-price volatility in the banking sector - reflected by a greater-than-11% decline in Live Oak Bancshares’ share price over the prior week.
  • Insider sales, even when executed under a prearranged 10b5-1 plan, can create short-term uncertainty among investors about insider sentiment.
  • Market reaction to earnings and analyst changes may not align with longer-term valuation assessments, introducing timing risk for investors relying on recent price moves.

More from Insider Trading

Marvell Technology President Sells $1.1M in Stock as Shares Trade Near Yearly High Apr 6, 2026 Edward Lampert Sells $58.5 Million in Lands’ End Stock; Company Posts Q4 Shortfall, Announces $100M Buyback Program Apr 6, 2026 NeonC/NeOnc President Buys $153,398 in Stock as Company Advances Financing and Clinical Timeline Apr 6, 2026 Edwards Lifesciences Executive Executes Option Exercise, Sells 1,019 Shares Apr 6, 2026 Penumbra Director Executes $32,822 Stock Sale Amid Deal and Upbeat Quarterly Results Apr 6, 2026